3-(2,4-dimethoxybenzylidene)anabaseine has been researched along with Liver Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, K; Fang, Q; Li, H; Li, XY; Luo, H; Song, XM; Wang, HY; Wang, YL; Wu, XJ; Yan, XT; Yang, XM; Zhang, Y; Zhang, ZZ | 1 |
1 other study(ies) available for 3-(2,4-dimethoxybenzylidene)anabaseine and Liver Diseases
| Article | Year |
|---|---|
GTS-21 ameliorates polymicrobial sepsis-induced hepatic injury by modulating autophagy through α7nAchRs in mice.
Topics: Alanine Transaminase; alpha7 Nicotinic Acetylcholine Receptor; Animals; Aspartate Aminotransferases; Autophagy; Benzylidene Compounds; Cytokines; Disease Models, Animal; Inflammation; Interleukin-6; Liver; Liver Diseases; Male; Mice; Mice, Inbred C57BL; Pyridines; Sepsis; Tumor Necrosis Factor-alpha | 2020 |